Application and Approval. As between the Parties, Ruthigen shall be the legal and beneficial owner of the Drug Approval Application and related Regulatory Approval in the Territory. If either Party receives notice of any reportable adverse event or similar regulatory notice within any country within the Territory, then both Parties will comply with their respective regulatory requirements and confer on the issue in good faith. * Confidential material redacted and separately filed with the Commission.
Appears in 2 contracts
Samples: License and Supply Agreement (Oculus Innovative Sciences, Inc.), License and Supply Agreement (Oculus Innovative Sciences, Inc.)
Application and Approval. As between the Parties, Ruthigen shall be the legal and beneficial owner of the Drug Approval Application and related Regulatory Approval in the Territory. If either Party receives notice of any reportable adverse event or similar regulatory notice within any country within the Territory, then both Parties will comply with their respective regulatory requirements and confer on the issue in good faith. * Confidential material redacted Portions of this exhibit, indicated by the xxxx β[ ]*,β were omitted and have been filed separately filed with the CommissionSecurities and Exchange Commission pursuant to an application requesting confidential treatment.
Appears in 2 contracts
Samples: License and Supply Agreement (Ruthigen, Inc.), License and Supply Agreement (Ruthigen, Inc.)